| 摘要 |
The invention relates to soft gelatine capsules with cytisine content for nicotine-replacement therapy. According to the invention, the capsules contain 1...1.5 parts of cytisine, 100...200 parts of olive oil, 40 parts of Passiflora sp. alcoholic extract, 40...50 parts of magnesium citrate, 60...150 parts of macromolecular hydrophillic agent, 5 parts of stabilizer, 2.5 parts of non-ionogenic surface-active agent and 40...50 parts of purified water. |
